Insight
London Market Monitor – 31 May 2022
Our May review of the markets and Solvency II discount rates.
This report provides an updated view of National Health Service England (NHSE) prescription drug expenditure for FY 2019/20. In FY 2019/20, NHSE spent £8.47 billion on prescription drugs prescribed by general practitioners. This level of expenditure has increased by approximately 5.25% from FY 2018/19.
Insight
Our May review of the markets and Solvency II discount rates.
We’re here to help you break through complex challenges and achieve next-level success.